Literature DB >> 21237267

Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines.

S B Rizwan1, D Assmus, A Boehnke, T Hanley, B J Boyd, T Rades, S Hook.   

Abstract

Different delivery strategies to improve the immunogenicity of peptide/protein-based vaccines are currently under investigation. In this study, the preparation and physicochemical characterisation of cubosomes, a novel lipid-based particulate system currently being explored for vaccine delivery, was investigated. Cubosomes were prepared from a liquid precursor mixture containing phytantriol or glycerylmonooleate (GMO), F127 for particle stabilisation, and a hydrotrope (ethanol or polyethylene glycol (PEG(200)) or propylene glycol (PG)). Several liquid precursors were prepared, and the effect of varying the concentrations of F127 and the hydrotrope on cubosome formation was investigated. Formulations were prepared by fragmentation for comparison. The model protein ovalbumin (Ova) was also entrapped within selected formulations. Submicron-sized particles (180-300 nm) were formed spontaneously upon dilution of the liquid precursors, circumventing the need for the preformed cubic phase used in traditional fragmentation-based methods. The nanostructure of the phytantriol dispersions was determined to be cubic phase using SAXS whilst GMO dispersions had a reverse hexagonal nanostructure coexisting with cubic phase. The greatest entrapment of Ova was within phytantriol cubosomes prepared from liquid precursors. Release of Ova from the various formulations was sustained; however, release was significantly faster and the extent of release was greater from fragmented dispersions compared to liquid precursor formulations. Taken together, these results suggest that phytantriol cubosomes can be prepared using liquid precursors and that it is a suitable alternative to GMO. Furthermore, the high entrapment and the slow release of Ova in vitro highlight the potential of phytantriol cubosomes prepared using liquid precursors as a novel vaccine delivery system.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237267     DOI: 10.1016/j.ejpb.2010.12.034

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  16 in total

Review 1.  Liquid Crystalline Phases for Enhancement of Oral Bioavailability.

Authors:  Xingwang Zhang; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2021-02-22       Impact factor: 3.246

Review 2.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

Review 3.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

4.  Investigating the Potential of Phosphatidylcholine-Based Nano-Sized Carriers in Boosting the Oto-Topical Delivery of Caroverine: in vitro Characterization, Stability Assessment and ex vivo Transport Studies.

Authors:  Amira Yousry Farrah; Abdulaziz M Al-Mahallawi; Emad B Basalious; Demiana I Nesseem
Journal:  Int J Nanomedicine       Date:  2020-11-13

Review 5.  Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.

Authors:  Giovana Calixto; Jéssica Bernegossi; Bruno Fonseca-Santos; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2014-08-08

6.  Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.

Authors:  Mona M Saber; Abdulaziz M Al-Mahallawi; Noha N Nassar; Björn Stork; Samia A Shouman
Journal:  BMC Cancer       Date:  2018-08-15       Impact factor: 4.430

7.  Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.

Authors:  Ni Zeng; Xiaoling Gao; Quanyin Hu; Qingxiang Song; Huimin Xia; Zhongyang Liu; Guangzhi Gu; Mengyin Jiang; Zhiqing Pang; Hongzhuan Chen; Jun Chen; Liang Fang
Journal:  Int J Nanomedicine       Date:  2012-07-13

8.  Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization.

Authors:  Teerawan Rattanapak; James C Birchall; Katherine Young; Atsuko Kubo; Sayumi Fujimori; Masaru Ishii; Sarah Hook
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

9.  Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochlea.

Authors:  Meng Bu; Jingling Tang; Yinghui Wei; Yanhui Sun; Xinyu Wang; Linhua Wu; Hongzhuo Liu
Journal:  Int J Nanomedicine       Date:  2015-11-03

10.  Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting.

Authors:  Heba M Aboud; Amira H Hassan; Adel A Ali; Abdel-Razik H Abdel-Razik
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.